Initial Staging Scans
Got my inital staging bone/brain and lung scans
Good news, I have no mets in the bone or brain.
Not so good news, I have 11 nodules throughout my lungs. Largest is 2cmx2cm. Most are smaller, under a cm in size.
I am at a crossroad as to which therepy to try. I wish I knew how fast they are growing and it may give me a idea.
I am considering the IL2 to try for a home run on knocking it back or out.
I am scheduling an appointment with Hopkins before I do anything. I want to investigate trials before I get on a pill that would exclude me from some of the trials. The ONC didn't see any problem going a couple of weeks before starting a treatment.
It seems the first time selecting Sunitnib Pazopanib or the like is a shot in the dark anyway. They have no idea if its working or if one woud work better without experimentation. I wish they could take a culture of my tumors and see what worked best.
I want to start on a treatment but not before I talk to several specialists from Hopkins and MD Anderson.
Matt
Comments
-
Staging
Matt:
you may have an idea of how fast once the tumor is graded; it can be 1-4 with 1 the least aggressive.
Good for you in seeking more opinions; renal cancer is a strange one with many things that a renal oncologist can provide the best information
Sarah
0 -
IL2
Bit rough but halted my cancer and even reduced it for a while
0 -
Good luck
Not a bad idea to get more opinions. It's one of the things that are big unknowns with treating our cancer. They don't know what treatments to use in what order (or even what to combine).
IL2 is rough.
I saw an RCC specialist at USC when my cancer returned in February. He said if it comes back again in the next year, he'd want to try IL2 before anything else. I asked about safety, he said he'd given treatment to something like 300 patients with one fatality (and they understood what happened in that case so it won't happen again). He said he's had great results with it.
I heard the other day that one of the PD-1 drugs just received fasttrack approval from the FDA. It might be worth a try. This is the immune based treatment. I believe it's had better results and lower toxicity than IL2. Did anybody mention it? Actually, I'm not sure if fasttrack approval means it's approved or means it's going to get approved faster. Still, might be worth looking into. And I think there's some studies that are combining it with one of the TKI's.
The good news is there are lots of things to try that have worked to varying degrees. That's great news.
Wishing you the best. Please keep us informed.
Todd
0 -
IL2todd121 said:Good luck
Not a bad idea to get more opinions. It's one of the things that are big unknowns with treating our cancer. They don't know what treatments to use in what order (or even what to combine).
IL2 is rough.
I saw an RCC specialist at USC when my cancer returned in February. He said if it comes back again in the next year, he'd want to try IL2 before anything else. I asked about safety, he said he'd given treatment to something like 300 patients with one fatality (and they understood what happened in that case so it won't happen again). He said he's had great results with it.
I heard the other day that one of the PD-1 drugs just received fasttrack approval from the FDA. It might be worth a try. This is the immune based treatment. I believe it's had better results and lower toxicity than IL2. Did anybody mention it? Actually, I'm not sure if fasttrack approval means it's approved or means it's going to get approved faster. Still, might be worth looking into. And I think there's some studies that are combining it with one of the TKI's.
The good news is there are lots of things to try that have worked to varying degrees. That's great news.
Wishing you the best. Please keep us informed.
Todd
It is a bit rough. Its not unbearable. If I was offered it, I would do it again in a nanosecond.
0 -
Approval of checkmate 025todd121 said:Good luck
Not a bad idea to get more opinions. It's one of the things that are big unknowns with treating our cancer. They don't know what treatments to use in what order (or even what to combine).
IL2 is rough.
I saw an RCC specialist at USC when my cancer returned in February. He said if it comes back again in the next year, he'd want to try IL2 before anything else. I asked about safety, he said he'd given treatment to something like 300 patients with one fatality (and they understood what happened in that case so it won't happen again). He said he's had great results with it.
I heard the other day that one of the PD-1 drugs just received fasttrack approval from the FDA. It might be worth a try. This is the immune based treatment. I believe it's had better results and lower toxicity than IL2. Did anybody mention it? Actually, I'm not sure if fasttrack approval means it's approved or means it's going to get approved faster. Still, might be worth looking into. And I think there's some studies that are combining it with one of the TKI's.
The good news is there are lots of things to try that have worked to varying degrees. That's great news.
Wishing you the best. Please keep us informed.
Todd
Thanks,
I heard they approved checkmate 25 and its fast tracked for limited use. I also read good results about checkmate 214 but accoring to Hopkins they are no longer taking applicants as of last week.
The doctors I have consulted say because I am younger (45) fit and no underlying conditions I would be a good candidate for IL2.
My worry is they don't know my progression rate until they scan me again in Nov.
My tumor was a grade 4 pt3b,pn0 nothing in my nodes which they removed, but I still have mets in the Lungs (11)
Matt
0
Discussion Boards
- All Discussion Boards
- 6 CSN Information
- 6 Welcome to CSN
- 121.8K Cancer specific
- 2.8K Anal Cancer
- 446 Bladder Cancer
- 309 Bone Cancers
- 1.6K Brain Cancer
- 28.5K Breast Cancer
- 397 Childhood Cancers
- 27.9K Colorectal Cancer
- 4.6K Esophageal Cancer
- 1.2K Gynecological Cancers (other than ovarian and uterine)
- 13K Head and Neck Cancer
- 6.4K Kidney Cancer
- 671 Leukemia
- 792 Liver Cancer
- 4.1K Lung Cancer
- 5.1K Lymphoma (Hodgkin and Non-Hodgkin)
- 237 Multiple Myeloma
- 7.1K Ovarian Cancer
- 61 Pancreatic Cancer
- 487 Peritoneal Cancer
- 5.5K Prostate Cancer
- 1.2K Rare and Other Cancers
- 539 Sarcoma
- 730 Skin Cancer
- 653 Stomach Cancer
- 191 Testicular Cancer
- 1.5K Thyroid Cancer
- 5.8K Uterine/Endometrial Cancer
- 6.3K Lifestyle Discussion Boards